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In the latter part of the 1990s, many companies have worked to
foster a `matrix’ style culture through several changes in organiza-
tional structure. This type of culture facilitates communication and
development of new technology across organizational and global
boundaries. At Glaxo Wellcome, this matrix culture is re￿ ected in
an automation strategy that relies on both centralized and
decentralized resources. The Group Development Operations
Information Systems Robotics Team is a centralized resource
providing development, support, integration, and training in
laboratory automation across businesses in the Development organ-
ization. The matrix culture still presents challenges with respect to
communication and managing the development of technology. A
current challenge for our team is to go beyond our recognized role
as a technology resource and actually to in￿ uence automation
strategies across the global Development organization. We shall
provide an overview of our role as a centralized resource, our team
strategy, examples of current and past successes and failures, and
future directions.
Introduction
After the merger of Burroughs Wellcome and Glaxo,
Inc., in 1995, a centralized robotics team was formed in
the Development Information Services organization.
This team was formed to support all departments in
Development with close ties to both the Research and
Manufacturing organizations. Prior to formation, auto-
mation resources were completely decentralized in the
previous companies. Today at Glaxo Wellcome, we rely
on both centralized and decentralized resources to devel-
op and integrate automation.
The decentralized resources consist of automation experts
located in each department. These experts focus on their
particular business needs and help to coordinate auto-
mation e¶ orts within their own organization. While
experts are needed in each department, they are often
not able to focus on global automation issues because of
other responsibilities that they may have within their
departments. The centralized automation team consists
of four members; three in the US and one in the UK, and
a manager in the US. Location within the Development
IS organization positions the team as a core service for all
departments within Development (® gure 1).
The centralized team performs the same activities as the
departmental automation employees with an emphasis
on encapsulating common processes and transferring
technology across departments. Team members were
chosen based on their passion for automation, desired
skill set (depth in di¶ erent areas), and proven abilities in
teamwork. One current challenge for this team is a
perception that we still are not close enough to fully
understand business needs. Another challenge is that we
currently have no formal mechanism for interaction with
the departments.
Strategy
In the Development organization at Glaxo Wellcome, we
rely on a strategy that is based on centralized and
decentralized resources that ` mutually in¯ uence’ each
other. We accomplish this by the following.
. Developing partnerships with departmental leaders
in automation. These leaders are familiar with com-
bining the science with automation and will often
become the business focus person in coordinating
e¶ orts of applying technology.
. Developing departmental leaders in automation by
training/mentoring those that have an interest in
automation. We have achieved this through ` bor-
rowing’ employees from departments for speci® c
projects or for a predetermined amount of time.
As these employees gain experience they also gain
in¯ uence in leading automation e¶ orts in their
departments.
. Relying on management support, which is vital in
ensuring success through communication and edu-
cation of automation e¶ orts at higher levels in the
company. Department managers need to know
about the resources that are available to them.
Additionally, management support is needed to
secure resources when needed.
Business principles
. Task targeted automation: this is the concept of
automating a single, well-de® ned task or a small
group of tasks instead of automating an entire
process. This has also been referred to as modular
automation or the ` workstation approach’ to auto-
mation. Applying this principle reduces development
time, increases ¯ exibility, lowers development/sup-
port costs, and facilitates duplication.
. Identify common activities: no automation project
begins without thoroughly researching previous
experience in the area of interest. This allows us to
® nd the highest common denominator to start from.
It also facilitates duplication if we can work at the
highest level possible.
. Fully exploit vendor software/hardware: we choose
this route whenever possible because it allows us to
start with proven technology. We choose to extend
the functionality of vendor supplied hardware/
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http://www.tandf.co.uk/journals 195software versus starting from scratch. This principle
will ultimately assist vendors in product develop-
ment.
. Prototype the proposed solution: this quickly
exposes unexpected issues and allows for proof of
concept.
Examples
Automation successes
For our group, successful implementation of automation
is de® ned as follows:
. documentation is complete;
. use of the application/system;
. replication of the application/system;
. positive feedback from users.
The following are examples of successful automation
projects that have been completed/updated in the past
year.
Platform:
BenchMate
TM (Zymark Corp., Hopkinton, MA) (® gure
2).
Highlights:
. reuse of unused equipment;
. simple, single process;
. replicated 7 times globally.
Platform:
Tecan Genesis (Tecan US, RTP, NC) (® gure 3).
Highlights:
. common process for GxP labs;
. replicated 7 times globally.
Assay developed to use MDCK cells as an alternative to
Caco-2 cells.
Platform:
Tecan Genesis Workstation (® gure 4).
Highlights:
. new, patented technology: cells-on-sheets device
[1];
. improved cell maintenance capabilities;
. designed with automation in mind;
. replicated 4 times globally.
Platform:
Gilson1 215 Liquid Handler (Gilson Inc., Middleton,
WI) (® gure 5).
Figure 1. Organizational view of the Centralized Automation
Team. Figure 2. Generic weighing application.
Figure 3. Gravimetric veri￿ cation of liquid handler performance.
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. cross-functional development;
. time savings of 1h versus 2 days for manual process;
. data from system are in good agreement with his-
torical results;
. will be replicated in 2000.
Other successful automation projects for our team this
year are as follows.
. Joblist: Microsoft
1 Excel macro to extend the func-
tionality of Tecan Logic software. This macro is
currently used on 25 systems.
. Generic paging application for detection of instru-
ment error and end events. This application is cur-
rently used on 10 systems.
. Tecan LUO: ewxtends functionality of PCS
(Productivity, Communications and Scheduling
Software, Zymark Corp., Hopkinton, MA) on
Zymate
1 systems to run Tecan Logic and Gemini
methods on Genesis Workstations. This LUO is cur-
rently used on 7 systems.
. Custom training: Negotiated a custom training class
with Tecan for 19 Glaxo Wellcome employees.
Current implementations
We are also in the process of implementing several
projects as follows.
Platform:
HP ChemStation (Hewlett-Packard GmbH, Waldbronn,
Germany) (® gure 6) and Gilson1 215 Liquid Handler
(Gilson, Inc., Middleton, WI).
Highlights:
. will potentially double analysis throughput;
. cost savings of about $300000 per installation;
. coordination of Chemstation macros with Gilson
1
modules.
Platform:
custom system developed by Spectrum Systems, LLC
(Greenville, SC) (® gure 7).
Highlights:
. partnered with outside vendor for development;
. uses technology from the manufacturing environ-
ment.
Other automation projects currently under implementa-
tion by our team this year are:
. addition of automated ¯ ow control of nitrogen on a
Zymark 96-well evaporator;
. gravimetric tracking on liquid handlers;
. reaction optimization system.
Stumbling blocks
In an e¶ ort to continually improve our ability to provide
e¶ ective automation solutions, it is important for us to
Figure 4. Automation of intestinal absorption screen.
Figure 5. Automation of pH solubility/stability screen.
Figure 6. High throughput LC/MS system.
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past several years, we have had four projects that were
not completed. We have improved project delivery by
focusing on the following.
. Quantify need: we now use tools such as cost/bene-
® ts analysis and user surveys to determine the value
of a project.
. Fully understand process details: we strive even
harder to learn as much as we can about the current
process before starting an automation project.
. Avoid being ` too’ creative: we focus on o¶ ering ¯ ex-
ibility only where it is needed. This is referred to as
` non-restrictive standardization’ .
Future plans
. Enhance global communication: our location in the
Development organization at Glaxo Wellcome puts
us in a position to improve global communication in
automation. Several potential vehicles for this
include a development of a corporate ` knowledge
network’ , newsletter, and our involvement in the
Southeast Chapter of the Laboratory Robotics
Interest Group (LRIG).
. Work with department leaders to re® ne processes:
this will provide the groundwork to make automa-
tion feasible.
. Guide strategy in global processes: we are working
to become involved in several global initiatives that
are in need of a de® ned automation strategy.
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